

Generic Name: Anhydrous crystalline maltose
ACM, disaccharide.
Anhydrous crystalline maltose has been used as a food stabilizer and a desiccant (chemical agent used to absorb moisture) for use in foods, cosmetics, and pharmaceuticals.
Anhydrous crystalline maltose has been studied in patients with Sjogren's syndrome (inflammatory autoimmune disorder) for treatment of dry mouth.
Limited information is currently available about the effects of anhydrous crystalline maltose for the treatment of any indication in humans.
Dry mouth (Sjogren's syndrome) :
Anhydrous crystalline maltose (ACM) has been studied and may be effective for relieving symptoms of dry mouth associated with Sjogren's syndrome (inflammatory autoimmune disorder characterized by a dry mouth and dry eyes). Additional study is needed.
Grade: C
There is no proven effective dose for anhydrous crystalline maltose. However, 200-milligram lozenges have been taken by mouth three times a day for up to 24 weeks for relief of dry mouth in Sjogren's syndrome.
There is no proven safe or effective dose for anhydrous crystalline maltose in children.
Avoid in individuals with a known allergy or hypersensitivity to anhydrous crystalline maltose.
Anhydrous crystalline maltose appears safe, although there is a lack of available reports on adverse events. Avoid in patients with a known allergy or hypersensitivity to anhydrous crystalline maltose.
Anhydrous crystalline maltose is not recommended in pregnant or breastfeeding women due to a lack of available scientific evidence.
Insufficient available evidence.
Insufficient available evidence.
This information is based on a systematic review of scientific literature, and was peer-reviewed and edited by contributors to the Natural Standard Research Collaboration (www.naturalstandard.com): J. Kathryn Bryan, BA (Natural Standard Research Collaboration); Dilys Burke, BA (Natural Standard Research Collaboration); Nicole Giese, MS (Natural Standard Research Collaboration); Shaina Tanguay-Colucci, BS (Natural Standard Research Collaboration); Catherine Ulbricht, PharmD (Massachusetts General Hospital); Wendy Weissner, BA (Natural Standard Research Collaboration).
Fox PC, Cummins MJ, Cummins JM. A third study on the use of orally administered anhydrous crystalline maltose for relief of dry mouth in primary Sjogren's syndrome. J Altern Complement Med 2002;8(5):651-659.
Fox PC, Cummins MJ, Cummins JM. Use of orally administered anhydrous crystalline maltose for relief of dry mouth. J Altern Complement Med 2001;7(1):33-43.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.


